NO810773L - Fremgangsmaate for fremstilling av en genetisk modifisert mikroorganisme, samt anvendelse av mikroorganismen - Google Patents
Fremgangsmaate for fremstilling av en genetisk modifisert mikroorganisme, samt anvendelse av mikroorganismenInfo
- Publication number
- NO810773L NO810773L NO810773A NO810773A NO810773L NO 810773 L NO810773 L NO 810773L NO 810773 A NO810773 A NO 810773A NO 810773 A NO810773 A NO 810773A NO 810773 L NO810773 L NO 810773L
- Authority
- NO
- Norway
- Prior art keywords
- microorganism
- gene
- gdh
- plasmid
- genetically modified
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title claims description 86
- 238000000034 method Methods 0.000 title claims description 39
- 238000002360 preparation method Methods 0.000 title description 4
- 101150019455 gdh gene Proteins 0.000 claims description 95
- 239000013612 plasmid Substances 0.000 claims description 76
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 65
- 108090000623 proteins and genes Proteins 0.000 claims description 49
- 101150099894 GDHA gene Proteins 0.000 claims description 37
- 229910021529 ammonia Inorganic materials 0.000 claims description 32
- 238000012546 transfer Methods 0.000 claims description 24
- 241000588724 Escherichia coli Species 0.000 claims description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 22
- 238000004519 manufacturing process Methods 0.000 claims description 18
- 241000863393 Methylophilus methylotrophus Species 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- 239000012634 fragment Substances 0.000 claims description 15
- 108010027322 single cell proteins Proteins 0.000 claims description 15
- 241000894006 Bacteria Species 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 108091008146 restriction endonucleases Proteins 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 101150007092 Glt gene Proteins 0.000 claims description 8
- 239000013600 plasmid vector Substances 0.000 claims description 8
- 239000013598 vector Substances 0.000 claims description 7
- 230000007246 mechanism Effects 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 3
- 230000035772 mutation Effects 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 239000013067 intermediate product Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 54
- 108020004414 DNA Proteins 0.000 description 38
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 20
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 20
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 15
- 230000004048 modification Effects 0.000 description 15
- 238000012986 modification Methods 0.000 description 15
- 230000037361 pathway Effects 0.000 description 14
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 7
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 7
- 241000589516 Pseudomonas Species 0.000 description 6
- 108010029645 galactitol 2-dehydrogenase Proteins 0.000 description 6
- 229930195712 glutamate Natural products 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 230000002950 deficient Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000665 guar gum Substances 0.000 description 5
- 230000013011 mating Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000000661 sodium alginate Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 229950006238 nadide Drugs 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 108020000311 Glutamate Synthase Proteins 0.000 description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- -1 ammonium ions Chemical class 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000012239 gene modification Methods 0.000 description 3
- 230000005017 genetic modification Effects 0.000 description 3
- 235000013617 genetically modified food Nutrition 0.000 description 3
- 230000028744 lysogeny Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 241000588748 Klebsiella Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000589344 Methylomonas Species 0.000 description 2
- 241000863391 Methylophilus Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102000001218 Rec A Recombinases Human genes 0.000 description 2
- 108010055016 Rec A Recombinases Proteins 0.000 description 2
- QOTAEASRCGCJDN-UHFFFAOYSA-N [C].CO Chemical compound [C].CO QOTAEASRCGCJDN-UHFFFAOYSA-N 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 229960001456 adenosine triphosphate Drugs 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 101150041871 gltB gene Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000003471 mutagenic agent Substances 0.000 description 2
- 231100000707 mutagenic chemical Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
- AGFIRQJZCNVMCW-UAKXSSHOSA-N 5-bromouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 AGFIRQJZCNVMCW-UAKXSSHOSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101001015612 Halomonas elongata (strain ATCC 33173 / DSM 2581 / NBRC 15536 / NCIMB 2198 / 1H9) Glutamate synthase [NADPH] large chain Proteins 0.000 description 1
- 101001040070 Halomonas elongata (strain ATCC 33173 / DSM 2581 / NBRC 15536 / NCIMB 2198 / 1H9) Glutamate synthase [NADPH] small chain Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000364057 Peoria Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 240000001377 Pseudomonas sp. PM-2 Species 0.000 description 1
- 101000888131 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Glutamate synthase [NADH] Proteins 0.000 description 1
- CTCBPRXHVPZNHB-VQFZJOCSSA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate;(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O.C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O CTCBPRXHVPZNHB-VQFZJOCSSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- HQQSBEDKMRHYME-UHFFFAOYSA-N pefloxacin mesylate Chemical compound [H+].CS([O-])(=O)=O.C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCN(C)CC1 HQQSBEDKMRHYME-UHFFFAOYSA-N 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
- C12N9/0016—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/32—Processes using, or culture media containing, lower alkanols, i.e. C1 to C6
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8007849 | 1980-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO810773L true NO810773L (no) | 1981-09-08 |
Family
ID=10511943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO810773A NO810773L (no) | 1980-03-07 | 1981-03-06 | Fremgangsmaate for fremstilling av en genetisk modifisert mikroorganisme, samt anvendelse av mikroorganismen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0035831B1 (fr) |
| JP (1) | JPS56140893A (fr) |
| AU (1) | AU6737281A (fr) |
| CA (1) | CA1187011A (fr) |
| DK (1) | DK95281A (fr) |
| ES (1) | ES500171A0 (fr) |
| IE (1) | IE51191B1 (fr) |
| NO (1) | NO810773L (fr) |
| PL (1) | PL148391B1 (fr) |
| PT (1) | PT72630B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK140481A (da) * | 1980-03-28 | 1981-09-29 | Ici Ltd | Modifikation af mikroorganismer |
| DE3271643D1 (en) * | 1981-07-08 | 1986-07-17 | Ici Plc | Method for the purification of urease and glutamate dehydrogenase |
| EP0098967B1 (fr) * | 1982-06-11 | 1989-08-09 | Hoechst Aktiengesellschaft | Procédé pour la préparation de bactéries obligatoirement méthylotrophes, exprimant de l'ADN étranger, plasmides et organismes hôtes appropriés à cet effet |
| US4535060A (en) * | 1983-01-05 | 1985-08-13 | Calgene, Inc. | Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthetase, production and use |
| CA1277931C (fr) * | 1984-06-05 | 1990-12-18 | Shimon Ulitzur | Detection et (ou) identification de microorganismes dans les echantillons a l'aide de la bioluminescence et d'autres marqueurs exogenes introduits par manipulation genetique |
| FR2569723B1 (fr) * | 1984-08-31 | 1986-09-19 | Centre Nat Rech Scient | Application des antibiotiques de la famille des phleomycines a titre d'agent de selection dans le domaine du genie genetique |
| JP4416866B2 (ja) * | 1998-07-30 | 2010-02-17 | オリエンタル酵母工業株式会社 | カルシウム測定用液状試薬 |
| RU2250266C2 (ru) | 1999-04-09 | 2005-04-20 | Адзиномото Ко., Инк. | Способ получения l-аминокислоты |
| DE60034843T2 (de) * | 1999-06-03 | 2008-01-17 | Ajinomoto Co., Inc. | Verfahren zur Herstellung von L-arginin |
| RU2202607C2 (ru) | 2000-03-03 | 2003-04-20 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" | Штамм бактерий methylophilus methylotrophus - продуцент l-фенилаланина (варианты), способ получения l-фенилаланина |
| US6911332B2 (en) | 2002-06-12 | 2005-06-28 | Ajinomoto Co., Inc. | Isolated polynucleotides encoding d-arabino-3-hexulose-6-phosphate synthases from Methylophilus methylotrophus |
| US7060475B2 (en) | 2003-02-28 | 2006-06-13 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in methylophilus methylotrophus |
| US7026149B2 (en) | 2003-02-28 | 2006-04-11 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in the stress response to environmental changes in Methylophilus methylotrophus |
| US7029893B2 (en) | 2003-02-28 | 2006-04-18 | Ajinomoto Co., Inc. | Polynucleotides encoding polypeptides involved in amino acid biosynthesis in methylophilus methylotrophus |
| WO2009119402A1 (fr) | 2008-03-24 | 2009-10-01 | パナソニック電工株式会社 | Capteur |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2003926B (en) * | 1977-09-08 | 1982-03-17 | Ici Ltd | Microbiological process |
| BE870188A (fr) * | 1977-09-08 | 1979-03-05 | Ici Ltd | Procede microbiologique |
| DK140481A (da) * | 1980-03-28 | 1981-09-29 | Ici Ltd | Modifikation af mikroorganismer |
-
1981
- 1981-02-10 EP EP81300538A patent/EP0035831B1/fr not_active Expired
- 1981-02-16 IE IE305/81A patent/IE51191B1/en unknown
- 1981-02-17 AU AU67372/81A patent/AU6737281A/en not_active Abandoned
- 1981-03-03 DK DK95281A patent/DK95281A/da not_active Application Discontinuation
- 1981-03-06 PL PL1981230034A patent/PL148391B1/pl unknown
- 1981-03-06 PT PT72630A patent/PT72630B/pt unknown
- 1981-03-06 NO NO810773A patent/NO810773L/no unknown
- 1981-03-06 ES ES500171A patent/ES500171A0/es active Granted
- 1981-03-07 JP JP3305881A patent/JPS56140893A/ja active Pending
- 1981-03-09 CA CA000372550A patent/CA1187011A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0035831B1 (fr) | 1986-01-08 |
| EP0035831A3 (en) | 1982-03-31 |
| DK95281A (da) | 1981-09-08 |
| CA1187011A (fr) | 1985-05-14 |
| AU6737281A (en) | 1981-09-10 |
| ES8301503A1 (es) | 1982-12-01 |
| JPS56140893A (en) | 1981-11-04 |
| PL148391B1 (en) | 1989-10-31 |
| PL230034A1 (en) | 1983-07-18 |
| IE810305L (en) | 1981-09-07 |
| PT72630B (en) | 1982-03-19 |
| EP0035831A2 (fr) | 1981-09-16 |
| IE51191B1 (en) | 1986-10-29 |
| ES500171A0 (es) | 1982-12-01 |
| PT72630A (en) | 1981-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7125695B2 (en) | Directed evolution of microorganisms | |
| NO810773L (no) | Fremgangsmaate for fremstilling av en genetisk modifisert mikroorganisme, samt anvendelse av mikroorganismen | |
| US10633684B2 (en) | Production of riboflavin | |
| Tutino et al. | A novel replication element from an Antarctic plasmid as a tool for the expression of proteins at low temperature | |
| US7670824B2 (en) | Multicopy-integration of heterologous genes and expression in Methylobacterium | |
| CN101679490B (zh) | 通过mRNA的稳定化提高目标产物的生产 | |
| Petruschka et al. | The cyo operon of Pseudomonas putida is involved in carbon catabolite repression of phenol degradation | |
| CN1973043A (zh) | 不包含抗生素抗性基因的rsf1010衍生mob－缺陷型质粒、包含该质粒的细菌和生产有用代谢物的方法 | |
| Smith et al. | Mutagenesis of soluble methane monooxygenase | |
| Bigas et al. | Development of a genetic manipulation system for Haemophilus parasuis | |
| Choi et al. | Multicopy integration and expression of heterologous genes in Methylobacterium extorquens ATCC 55366 | |
| Hommes et al. | Mutagenesis of hydroxylamine oxidoreductase in Nitrosomonas europaea by transformation and recombination | |
| SK280580B6 (sk) | Fragment dna, vektor a mikroorganizmus obsahujúci | |
| Bedore et al. | Natural transformation as a tool in Acinetobacter baylyi: streamlined engineering and mutational analysis | |
| US10717999B2 (en) | Method for the fermentative production of L-lysine using C. glutamicum strains with a mutated kup transporter | |
| EP3599282B1 (fr) | Procédé de production de l-lysine par fermentation | |
| Ludwig et al. | Transformation and gene replacement in the facultatively chemoheterotrophic, unicellular cyanobacterium Synechocystis sp. PCC6714 by electroporation | |
| CN1946844B (zh) | 通过利用两个染色体外元件在原核细胞中产生重组基因 | |
| Chen et al. | Characterization of a cryptic plasmid from Pseudomonas sp. and utilization of its temperature-sensitive derivatives for genetic manipulation | |
| CA2553485C (fr) | Integration multicopie et expression de genes heterologues dans un methylbacterium | |
| US20030175854A1 (en) | System and method for gene expression in thermus strains | |
| Jansen et al. | A robust life-or-death selection platform for enzyme evolution | |
| JP4312832B2 (ja) | インビボ組換え | |
| Dowling et al. | Genetically engineered fluorescent pseudomonads for improved biocontrol of plant pathogens | |
| Patel | Random Mutagenesis and Selection for RubisCO Function in the Photosynthetic Bacterium Rhodobacter capsulatus |